XML 59 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
DISTRIBUTION AGREEMENTS AND MAJOR CUSTOMERS (Detail Textuals 1) (Brachytherapy Seed, USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended 12 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2012
C R Bard
Jun. 30, 2011
C R Bard
Jun. 30, 2012
C R Bard
Jun. 30, 2011
C R Bard
Dec. 31, 2011
C R Bard
Jun. 30, 2011
Core Oncology
Jun. 30, 2011
Core Oncology
Feb. 17, 2012
Core Oncology
Dec. 31, 2011
Core Oncology
Revenue, Major Customer [Line Items]                  
Percentage of accounts receivable 16.00%   16.00%   19.00%        
Percentage of consolidated accounts receivable     Less than 10%   Less than 10%        
Percentage of revenue 23.00% 27.00% 26.00% 28.00%   13.00% 10.00%    
Allowance for doubtful accounts receivable                 $ 2.2
Allowances for accounts receivable, written off               $ 2.2